Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Source:http://linkedlifedata.com/resource/pubmed/id/7754011

Download in:

View as

General Info

PMID
7754011